Literature DB >> 15527445

Stroke recurrence within the first year following cerebral infarction--Tottori University Lacunar Infarction Prognosis Study (TULIPS).

Takao Soda1, Hiroyuki Nakayasu, Masanobu Maeda, Masayoshi Kusumi, Hisanori Kowa, Etsuko Awaki, Jun Saito, Kenji Nakashima.   

Abstract

OBJECTIVES: To identify determinants of recurrence after ischemic stroke in the Japanese population.
MATERIALS AND METHODS: We enrolled 885 patients with acute ischemic stroke that had been admitted to our community hospitals. A total of 831 cases were followed for 1 year after the index stroke. Patients were assigned to one of the ischemic stroke subtype groups based on the NINDS Stroke Data Bank criteria.
RESULTS: Rates of stroke recurrence were significantly different among stroke subtype groups: 14.4% in cardioembolic infarction, 7.3% in atherothrombotic infarction (ATI), 6.2% in lacunar infarction (LI) and 7.8% in infarction of uncertain cause. Previous history of stroke was the predictor of stroke recurrence for the groups of ATI and LI patients, and diabetes mellitus was the predictor of recurrence for the group of LI patients.
CONCLUSION: The rate of recurrence and risk factors for stroke recurrence are different by stroke subtypes.

Entities:  

Mesh:

Year:  2004        PMID: 15527445     DOI: 10.1111/j.1600-0404.2004.00290.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial.

Authors:  Robert G Hart; Lesly A Pearce; Majid F Bakheet; Oscar R Benavente; Robin A Conwit; Leslie A McClure; Robert L Talbert; David C Anderson
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-06-22       Impact factor: 2.136

2.  Clinical manifestation of cancer related stroke: retrospective case-control study.

Authors:  Jeong-Min Kim; Keun-Hwa Jung; Kee Hong Park; Soon-Tae Lee; Kon Chu; Jae-Kyu Roh
Journal:  J Neurooncol       Date:  2013-01-09       Impact factor: 4.130

Review 3.  Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction.

Authors:  Caroline Jackson; Cathie Sudlow
Journal:  Brain       Date:  2005-09-29       Impact factor: 13.501

4.  Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.

Authors:  Carole L White; Jeff M Szychowski; Ana Roldan; Marie-France Benavente; Edwin J Pretell; Oscar H Del Brutto; Carlos S Kase; Antonio Arauz; Brett C Meyer; Irene Meissner; Bart M Demaerschalk; Leslie A McClure; Christopher S Coffey; Lesly A Pearce; Robin Conwit; Lisa H Irby; Kalyani Peri; Pablo E Pergola; Robert G Hart; Oscar R Benavente
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-04-17       Impact factor: 2.136

5.  [Driving ability with cerebral perfusion disorders].

Authors:  P Marx
Journal:  Nervenarzt       Date:  2014-07       Impact factor: 1.214

6.  Small vessel cerebrovascular disease: the past, present, and future.

Authors:  Réza Behrouz; Ali R Malek; Michel T Torbey
Journal:  Stroke Res Treat       Date:  2012-01-24

Review 7.  Cancer-related stroke: Exploring personalized therapy strategies.

Authors:  Yu-Jie Chen; Rui-Guo Dong; Meng-Meng Zhang; Chao Sheng; Peng-Fei Guo; Jie Sun
Journal:  Brain Behav       Date:  2022-08-08       Impact factor: 3.405

8.  Five-year prognosis after mild to moderate ischemic stroke by stroke subtype: a multi-clinic registry study.

Authors:  Yumei Lv; Xianghua Fang; Karam Asmaro; Hongjun Liu; Xinqing Zhang; Hongmei Zhang; Xiaoming Qin; Xunming Ji
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

9.  Treatment of EGFR mutation-positive non-small cell lung cancer complicated by Trousseau syndrome with gefitinib followed by osimertinib: a case report.

Authors:  Yoshikane Nonagase; Masayuki Takeda; Kaoru Tanaka; Hidetoshi Hayashi; Tsutomu Iwasa; Kazuhiko Nakagawa
Journal:  Oncotarget       Date:  2018-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.